These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 24813797)

  • 1. [Strategic construction of an innovative drug development pipeline by industry-academia cooperation - consortium for drug innovation in the Tokai region of Japan].
    Akaike A
    Nihon Yakurigaku Zasshi; 2014 May; 143(5):254-9. PubMed ID: 24813797
    [No Abstract]   [Full Text] [Related]  

  • 2. [Open innovation: public-private partnerships in pharmaceutical R&D].
    Uchibayashi N
    Nihon Yakurigaku Zasshi; 2013 Jul; 142(1):32-8. PubMed ID: 23842226
    [No Abstract]   [Full Text] [Related]  

  • 3. [Open innovation and licensing in the pharmaceutical industry].
    Yamasaki M
    Nihon Yakurigaku Zasshi; 2013 Jul; 142(1):28-31. PubMed ID: 23842225
    [No Abstract]   [Full Text] [Related]  

  • 4. [Requirements for the license-out of drug candidates to pharmaceutical companies].
    Tawara S; Kobayashi N; Arai H; Masumi S; Itoh S; Nakahara Y; Morimoto N; Itano Y; Yamaguchi T; Niwa K; Seki J; Nakamura K
    Nihon Yakurigaku Zasshi; 2014 Apr; 143(4):198-202. PubMed ID: 24717609
    [No Abstract]   [Full Text] [Related]  

  • 5. Open innovation and intellectual property: time for a reboot?
    Judd DB
    Drug Discov Today; 2013 Oct; 18(19-20):907-9. PubMed ID: 23958455
    [No Abstract]   [Full Text] [Related]  

  • 6. [Change the world through business partnering - commercialization of biotechnology and open-innovation].
    Tsukamoto Y
    Nihon Yakurigaku Zasshi; 2013 May; 141(5):268-74. PubMed ID: 23665558
    [No Abstract]   [Full Text] [Related]  

  • 7. [Drug Discovery and Medical Technology Program in RIKEN life science innovation].
    Yamaguchi T
    Nihon Yakurigaku Zasshi; 2013 Nov; 142(5):241-6. PubMed ID: 24212594
    [No Abstract]   [Full Text] [Related]  

  • 8. [Launch of new drug development support network led by iD3].
    Eno H
    Nihon Yakurigaku Zasshi; 2014 Jan; 143(1):34-9. PubMed ID: 24420135
    [No Abstract]   [Full Text] [Related]  

  • 9. [Consideration on Industry-Academia Partnering in Drug Discovery Development: Based on a Questionnaire Survey of Pharmaceutical Companies and Academia].
    Iida K; Yano T; Ikemori M; Ishida T; Nishimura N
    Yakugaku Zasshi; 2021 Jun; 141(6):877-886. PubMed ID: 33642438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Academia and industry: allocating credit for discovery and development of new therapies.
    Flier JS
    J Clin Invest; 2019 May; 129(6):2172-2174. PubMed ID: 31107243
    [No Abstract]   [Full Text] [Related]  

  • 11. [Consideration on Academia Environments for Creating Medical Innovation].
    Iida K; Ishida T; Nishimura N
    Yakugaku Zasshi; 2022 Jan; 142(1):75-84. PubMed ID: 34629350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The state of integration: today and tomorrow.
    Bohlmann RC
    Med Group Manage J; 1995; 42(1):24, 26, 28-9. PubMed ID: 10139537
    [No Abstract]   [Full Text] [Related]  

  • 13. [Expectation for the drug development activity in academia].
    Inagaki O
    Yakugaku Zasshi; 2013; 133(2):213-9. PubMed ID: 23370516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anecdotes from ITMAT: building capacity for translational science.
    FitzGerald GA
    Clin Pharmacol Ther; 2013 Sep; 94(3):291-6. PubMed ID: 23963214
    [No Abstract]   [Full Text] [Related]  

  • 15. Academia-pharma partnerships for novel drug discovery: essential or nice to have?
    Palmer M; Chaguturu R
    Expert Opin Drug Discov; 2017 Jun; 12(6):537-540. PubMed ID: 28394189
    [No Abstract]   [Full Text] [Related]  

  • 16. Affairs of the Heart: Innovation in Cardiovascular Research and Development.
    Honig P; Terzic A
    Clin Pharmacol Ther; 2017 Aug; 102(2):162-168. PubMed ID: 28718903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Academic-industrial partnerships in drug discovery in the age of genomics.
    Harris T; Papadopoulos S; Goldstein DB
    Trends Biotechnol; 2015 Jun; 33(6):320-2. PubMed ID: 25987446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Market watch: a framework for biomedical innovation in emerging markets.
    Gautam A; Yang S
    Nat Rev Drug Discov; 2014 Sep; 13(9):646-7. PubMed ID: 25176427
    [No Abstract]   [Full Text] [Related]  

  • 19. The future of integrated delivery systems. Interview by Meg Matheny.
    Campbell B
    Health Syst Lead; 1994 Aug; 1(6):23-6. PubMed ID: 10140115
    [No Abstract]   [Full Text] [Related]  

  • 20. Reinventing bioinnovation.
    Kaitin KI; Honig PK
    Clin Pharmacol Ther; 2013 Sep; 94(3):279-83. PubMed ID: 23963211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.